Sort
261,768 grants matching “gene therapy”
Deconstructing and Reconstructing the T Cell Signaling Network
$1,703,241Arthur Weiss · University Of California, San Francisco · P01 · FY2012 · AI
Deconstructing and Reconstructing the T Cell Signaling Network
$1,703,241Arthur Weiss · University Of California, San Francisco · P01 · FY2014 · AI
Deconstructing and Reconstructing the T Cell Signaling Network
$1,703,239Arthur Weiss · University Of California, San Francisco · P01 · FY2015 · AI
Comparative Biomedical Scientist Training Program
$1,702,988Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2020 · CA
GENE THERAPY FOR SICKLE CELL DISEASE
$1,702,910St. Jude Children'S Research Hospital · P01 · FY2001 · HL
Hormonal Control of Calcium Metabolism
$1,702,901John T Potts · Massachusetts General Hospital · P01 · FY2015 · DK
Papillomavirus Virion Proteins and Vaccines
$1,702,735John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Immune Responses to AAV-Mediated FIX Gene Transfer
$1,702,657Hildegund C. J. Ertl · Wistar Institute · P01 · FY2012 · HL
CAM Center for Epigenetic Regulation of Inflammation
$1,702,554Prakash S. Nagarkatti · University Of South Carolina At Columbia · P01 · FY2014 · AT
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,702,553Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Using functional genomics to inform gene environment interactions for colorectal cancer
$1,702,464Ulrike Peters · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Transcriptional and Epigenetic Signatures of Human Brain Development and Autism
$1,702,149Nenad Sestan · Yale University · U01 · FY2016 · MH
Comprehensive Phenotypic Comparison of Normal and Cancer Stem Cells
$1,702,016Ramesh A Shivdasani · Harvard University · RC2 · FY2010 · CA
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
$1,701,970Carl H. June · University Of Pennsylvania · P01 · FY2020 · CA
Gene Replacement Therapy in Hematopoietic Stem Cells
$1,701,496Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2005 · HL
Gene Replacement Therapy in Hematopoietic Stem Cells
$1,701,371Mary C Dinauer · Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2007 · HL
Linking Genetics, Genomics and Phenomics to Better Understand Asthma Severity
$1,701,308Deborah A. Meyers · Wake Forest University Health Sciences · RC2 · FY2009 · HL
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models
$1,701,222Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Ghrelin Deacylase as a Treatment for Opioid Polysubstance Abuse
$1,700,947Chang-Guo Zhan · University Of Kentucky · R01 · FY2022 · DA
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer
$1,700,692Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Prospective Study of Breast Cancer Survivorship
$1,700,560Kaiser Foundation Research Institute · R01 · FY2005 · CA
PEARL: Pathway Exploration and Analysis in Renal Lupus
$1,700,001Betty Diamond · Feinstein Institute For Medical Research · UH2 · FY2015 · AR
Curing Sickle Cell Disease with CRISPR-Cas9 genome editing
$1,700,000Mark C Walters · University Of California, San Francisco · OT2 · FY2019 · HL
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
$1,699,798Martin G Martin · University Of California Los Angeles · RC2 · FY2023 · DK
Pacific Northwest Udall Center
$1,699,692Thomas J Montine · Stanford University · P50 · FY2016 · NS